SEC 13F Intelligence

Highvista Strategies LLC / AMED

Highvista Strategies LLC’s Amedisys Inc Position

Does Highvista Strategies LLC own Amedisys Inc (AMED)? Not currently — the last reported position was 39.3K shares worth $4M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q2 2025
Shares
39.3K
% of Portfolio
+1.42%
Quarters Held
8
position exited

Position History AMED

Reported value by quarter
Q3 ’23: $4MQ3 ’23Q4 ’23: $4MQ4 ’23Q1 ’24: $4MQ1 ’24Q2 ’24: $4MQ2 ’24Q3 ’24: $4MQ3 ’24Q4 ’24: $4MQ4 ’24Q1 ’25: $4MQ1 ’25Q2 ’25: $4MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202539.3K$4M+1.42%
Q1 202539.3K$4M+1.40%
Q4 202439.3K$4M+1.33%
Q3 202439.3K$4M+1.31%
Q2 202439.3K$4M+1.32%
Q1 202439.3K$4M+1.29%
Q4 202339.3K$4M+1.35%
Q3 202339.3K$4M+1.70%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of AMED.